logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Virus Diseases

    FiltersReset Filters
    3 results
    • emtricitabine and tenofovir disoproxil fumarate

      (Emtricitabine and tenofovir disoproxil fumarate)
      NorthStar RxLLC
      Usage: Emtricitabine and tenofovir disoproxil fumarate are indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents for adults and children (≥17 kg). They are also used for HIV-1 pre-exposure prophylaxis (PrEP) in at-risk patients (≥35 kg) to reduce sexually acquired HIV-1 infection risk.
    • ribavirin

      (Ribavirin)
      Cameron Pharmaceuticals
      Usage: Ribavirin for Inhalation Solution is indicated for hospitalized infants and young children with severe lower respiratory tract infections caused by RSV. Treatment should ideally begin early in the course of infection, particularly for those with underlying conditions that may exacerbate clinical outcomes.
    • valganciclovir

      (Valganciclovir)
      Ajanta Pharma USA Inc.
      Usage: Valganciclovir tablets are indicated for treating Cytomegalovirus (CMV) retinitis in AIDS patients and for preventing CMV disease in high-risk kidney, heart, and kidney-pancreas transplant recipients. It is also used in pediatric patients aged 1 month to 16 years for preventing CMV disease post-transplant.